A total of 113 clinical Campylobacter strains (105 C. jejuni, 7 C. coli, 1 C. lari) were collected between 2006 and 2008 and tested for antimicrobial susceptibility to erythromycin, ciprofloxacin, doxycycline and meropenem. Of all the Campylobacter isolates, 52.2\% were resistant to ciprofloxacin and 38.0\% to doxycycline. None of them was resistant to erythromycin or meropenem. However, 51.3\% of all Campylobacter isolates were intermediate susceptible to erythromycin (minimum inhibitory concentration 1-4 mg/l). These data confirm the value of macrolides as the drugs of choice for the treatment of severe Campylobacter infections.
%0 Journal Article
%1 valenza_antimicrobial_2010
%A Valenza, Giuseppe
%A Frosch, Matthias
%A Abele-Horn, Marianne
%D 2010
%J Scandinavian Journal of Infectious Diseases
%K 80 Adolescent, Adult Adult, Aged, Agents, Bacterial, Campylobacter Campylobacter, Child, Drug Female, Germany, Hospitals, Humans, Infant, Infections, Male, Microbial Middle Newborn, Preschool, Resistance, Sensitivity Tests, University, Young ag_horn and over, {Anti-Bacterial}
%N 1
%P 57--60
%R 10.3109/00365540903283723
%T Antimicrobial susceptibility of clinical Campylobacter isolates collected at a German university hospital during the period 2006-2008
%U http://www.ncbi.nlm.nih.gov/pubmed/20055727
%V 42
%X A total of 113 clinical Campylobacter strains (105 C. jejuni, 7 C. coli, 1 C. lari) were collected between 2006 and 2008 and tested for antimicrobial susceptibility to erythromycin, ciprofloxacin, doxycycline and meropenem. Of all the Campylobacter isolates, 52.2\% were resistant to ciprofloxacin and 38.0\% to doxycycline. None of them was resistant to erythromycin or meropenem. However, 51.3\% of all Campylobacter isolates were intermediate susceptible to erythromycin (minimum inhibitory concentration 1-4 mg/l). These data confirm the value of macrolides as the drugs of choice for the treatment of severe Campylobacter infections.
@article{valenza_antimicrobial_2010,
abstract = {A total of 113 clinical Campylobacter strains (105 C. jejuni, 7 C. coli, 1 C. lari) were collected between 2006 and 2008 and tested for antimicrobial susceptibility to erythromycin, ciprofloxacin, doxycycline and meropenem. Of all the Campylobacter isolates, 52.2\% were resistant to ciprofloxacin and 38.0\% to doxycycline. None of them was resistant to erythromycin or meropenem. However, 51.3\% of all Campylobacter isolates were intermediate susceptible to erythromycin (minimum inhibitory concentration 1-4 mg/l). These data confirm the value of macrolides as the drugs of choice for the treatment of severe Campylobacter infections.},
added-at = {2011-04-07T15:44:20.000+0200},
author = {Valenza, Giuseppe and Frosch, Matthias and {Abele-Horn}, Marianne},
biburl = {https://www.bibsonomy.org/bibtex/2bf157a09cebf3bc3c2a9862e24477e8a/hymi},
doi = {10.3109/00365540903283723},
interhash = {cfd3e0ba02872f0ce70bfa84b9cf1cb5},
intrahash = {bf157a09cebf3bc3c2a9862e24477e8a},
issn = {1651-1980},
journal = {Scandinavian Journal of Infectious Diseases},
keywords = {80 Adolescent, Adult Adult, Aged, Agents, Bacterial, Campylobacter Campylobacter, Child, Drug Female, Germany, Hospitals, Humans, Infant, Infections, Male, Microbial Middle Newborn, Preschool, Resistance, Sensitivity Tests, University, Young ag_horn and over, {Anti-Bacterial}},
note = {{PMID:} 20055727},
number = 1,
pages = {57--60},
timestamp = {2011-04-07T16:28:36.000+0200},
title = {Antimicrobial susceptibility of clinical Campylobacter isolates collected at a German university hospital during the period 2006-2008},
url = {http://www.ncbi.nlm.nih.gov/pubmed/20055727},
volume = 42,
year = 2010
}